Brief: Beta Drugs's Baddi Oncology Manufacturing Plant Receives ANVISA Approval
20/04/2023 04:35
April 20 (Reuters) - Beta Drugs Ltd BTAD.NS :
* CO'S ONCOLOGY MANUFACTURING PLANT RECEIVES ANVISA APPROVAL
* ANVISA NOD FOR ORAL SOLIDS, INJECTABLES FORMULATIONS
Source text for Eikon: ID:nNSE1PWMP4
Further company coverage: BTAD.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Beta Drugs
See all newsBrief: Beta Drugs Receives Oncology Portfolio Approvals In Azerbaijan
India's Beta Drugs jumps after regulatory milestones in Azerbaijan, Philippines
Brief: Beta Drugs Achieves Regulatory Milestones In Azerbaijan And Philippines
Brief: Beta Drugs To Buy 66.09% Of Nivian Life Sciences For 694 MLN Rupees
Brief: Beta Drugs Receives Dcgi Approval For Methotrexate Oral Solution